These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1989173)

  • 1. Inverse relationship between human leukocyte antigen match and development of coronary artery disease.
    Radovancevic B; Birovljev S; Vega JD; Lonquist JL; Sweeney MS; Vasiljevic JD; Van Buren CT; Kerman RH; Frazier OH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1144-5. PubMed ID: 1989173
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
    Rose ML
    J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of human leukocyte antigen matching in cardiac transplantation.
    Festenstein H; McCloskey D; Yacoub MH
    Semin Thorac Cardiovasc Surg; 1990 Jul; 2(3):213-20. PubMed ID: 2081230
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of HLA compatibility on the incidence of cardiac allograft vasculopathy after heart transplantation.
    Stempfle HU; Mudra H; Strom C; Angermann CE; Klauss V; Rieber J; Scholz S; Spes C; Uberfuhr P; Theisen K
    Transplant Proc; 1995 Jun; 27(3):1977-8. PubMed ID: 7792857
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.
    Taylor DO; Yowell RL; Kfoury AG; Hammond EH; Renlund DG
    J Heart Lung Transplant; 2000 Jun; 19(6):518-21. PubMed ID: 10867330
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.
    Cocanougher B; Ballantyne CM; Pollack MS; Payton-Ross C; Lowry R; Kleiman NS; Farmer JA; Noon GP; Short HD; Young JB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):233-6. PubMed ID: 8438282
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy.
    Olivari MT; Homans DC; Wilson RF; Kubo SH; Ring WS
    Circulation; 1989 Nov; 80(5 Pt 2):III111-5. PubMed ID: 2805289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine.
    Herskowitz A; Tamura F; Ueda K; Neumann DA; Slepian M; Rose NR; Beschorner WE; Baumgartner WA; Reitz BR; Sell KW
    J Heart Transplant; 1989; 8(1):11-9. PubMed ID: 2647926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome.
    Di Filippo S; Girnita A; Webber SA; Tsao S; Boyle GJ; Miller SA; Gandhi SK; Zeevi A
    Hum Immunol; 2005 May; 66(5):513-8. PubMed ID: 15935888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 13. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibodies in heart transplantation.
    Vasilescu ER; Ho EK; de la Torre L; Itescu S; Marboe C; Cortesini R; Suciu-Foca N; Mancini D
    Transpl Immunol; 2004 Jan; 12(2):177-83. PubMed ID: 14967316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
    Reinsmoen NL; Nelson K; Zeevi A
    Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covert presensitization to HLA antigens in parous heart and lung transplant recipients may predispose to early allograft rejection.
    Tait BD; Dandie WJ; Griffiths AP; Esmore DS; Snell GI; Bergin P; Williams TJ
    Transplant Proc; 1995 Jun; 27(3):2143-4. PubMed ID: 7792912
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children.
    Stastny P; Lavingia B; Fixler DE; Yancy CW; Ring WS
    Transplantation; 2007 Sep; 84(6):738-45. PubMed ID: 17893607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.